1. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatitis from the BREEZE‐AD7 Phase 3 randomized trial. (5th June 2021) Authors: Wollenberg, A.; Nakahara, T.; Maari, C.; Peris, K.; Lio, P.; Augustin, M.; Silverberg, J.I.; Rueda, M.J.; DeLozier, A.M.; Pierce, E.; Yang, F.E.; Sun, L.; Ball, S.; Tauber, M.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 7(2021) Page Start: 1543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improvement in symptoms of anxiety and depression in patients with atopic dermatitis after treatment with baricitinib. (2nd October 2021) Authors: Thyssen, J.P.; Lio, P.; Ball, S.; Pierce, E.; Sun, L.; Chen, Y.; Tan, J.K.L.; Augustin, M. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 2(2022) Page Start: e147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Infectome, diseasome and comorbidities of Zika infection. (December 2016) Authors: Moni, M.; Lio, P. Journal: International journal of infectious diseases Issue: Volume 53(2016:Dec.)Supplement Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in normal skin. (1st December 2021) Authors: Maghfour, J.; Rietcheck, H.; Szeto, M. D.; Rundle, C. W.; Sivesind, T. E.; Dellavalle, R. P.; Lio, P.; Dunnick, C. A.; Fernandez, J.; Yardley, H. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in normal skin. (31st August 2021) Authors: Maghfour, J.; Rietcheck, H.; Szeto, M. D.; Rundle, C. W.; Sivesind, T. E.; Dellavalle, R. P.; Lio, P.; Dunnick, C. A.; Fernandez, J.; Yardley, H. Journal: Clinical and experimental dermatology Issue: Volume 46:Number 8(2021) Page Start: 1518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Issue 11 (22nd May 2017) Authors: Stalder, J.‐F.; Aubert, H.; Anthoine, E.; Futamura, M.; Marcoux, D.; Morren, M.‐A.; Trzeciak, M.; Szalai, Z.; Veres, K.; Deleuran, M.; Vestergaard, C.; Boralevi, F.; Chu, C.‐Y.; De Raeve, L.; Svensson, Å.; Fölster‐Holst, R.; Buchner, M.; Takaoka, R.; Aoki, V.; Chernyshov, P. Journal: Allergy Issue: Volume 72:Issue 11(2017:Nov.) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Issue 11 (22nd May 2017) Authors: Stalder, J.‐F.; Aubert, H.; Anthoine, E.; Futamura, M.; Marcoux, D.; Morren, M.‐A.; Trzeciak, M.; Szalai, Z.; Veres, K.; Deleuran, M.; Vestergaard, C.; Boralevi, F.; Chu, C.‐Y.; De Raeve, L.; Svensson, Å.; Fölster‐Holst, R.; Buchner, M.; Takaoka, R.; Aoki, V.; Chernyshov, P. Journal: Allergy Issue: Volume 72:Issue 11(2017:Nov.) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗